379 related articles for article (PubMed ID: 10920302)
1. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
[TBL] [Abstract][Full Text] [Related]
2. Cell-free 27 kDa heat shock protein (hsp27) and hsp27-cytochrome c complexes in the cervix of women with ovarian or endometrial cancer.
Korneeva I; Caputo TA; Witkin SS
Int J Cancer; 2002 Dec; 102(5):483-6. PubMed ID: 12432550
[TBL] [Abstract][Full Text] [Related]
3. IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Int J Cancer; 2000 Sep; 87(6):824-8. PubMed ID: 10956393
[TBL] [Abstract][Full Text] [Related]
4. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Hall KL; Dewar MA; Perchalski J
Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
[TBL] [Abstract][Full Text] [Related]
5. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
6. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
[TBL] [Abstract][Full Text] [Related]
7. Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women.
Genç MR; Karaşahin E; Onderdonk AB; Bongiovanni AM; Delaney ML; Witkin SS;
Am J Obstet Gynecol; 2005 Mar; 192(3):916-21. PubMed ID: 15746691
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
9. Allotypes and gynecological cancer.
Hitoglou-Hadji S; Makedos G; Papanicolaou A; Dozi-Vasiliadou I
Clin Exp Obstet Gynecol; 1997; 24(3):138-40. PubMed ID: 9478298
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
Konno R; Takano T; Sato S; Yajima A
Clin Cancer Res; 2000 Sep; 6(9):3576-80. PubMed ID: 10999747
[TBL] [Abstract][Full Text] [Related]
11. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
Ressel M; Köhler G
Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
[TBL] [Abstract][Full Text] [Related]
12. Detection of the human 70-kD and 60-kD heat shock proteins in the vagina: relation to microbial flora, vaginal pH, and method of contraception.
Giraldo P; Neuer A; Ribeiro-Filho A; Linhares I; Witkin SS
Infect Dis Obstet Gynecol; 1999; 7(1-2):23-5. PubMed ID: 10231004
[TBL] [Abstract][Full Text] [Related]
13. Optimum screening interventions for gynecologic malignancies.
Lea JS; Miller DS
Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
[TBL] [Abstract][Full Text] [Related]
14. IgM autoantibodies to 180- and 230- to 240-kd human epidermal proteins in pregnancy.
Borradori L; Didierjean L; Bernard P; Tamm K; Gaucherand M; Zurn A; Saurat JH
Arch Dermatol; 1995 Jan; 131(1):43-7. PubMed ID: 7826095
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoembryonic antigen in gynecological oncology].
Stiglmayer R
Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy.
Trieb K; Gerth R; Holzer G; Grohs JG; Berger P; Kotz R
Br J Cancer; 2000 Jan; 82(1):85-7. PubMed ID: 10638971
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein expression and immunity: relevance to gynecologic oncology.
Witkin SS
Eur J Gynaecol Oncol; 2001; 22(4):249-56. PubMed ID: 11695802
[TBL] [Abstract][Full Text] [Related]
18. [Heat shock proteins and malignancies of the female genital tract].
Piura B; Rabinovich A; Yavelsky V; Wolfson M
Harefuah; 2002 Nov; 141(11):969-72, 1010, 1009. PubMed ID: 12476632
[TBL] [Abstract][Full Text] [Related]
19. Role of PET in gynecologic malignancy.
Grigsby PW
Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
